Mendelian susceptibility to mycobacterial disease (MSMD) is a primary immunodeficiency syndrome characterized by severe disease caused by weakly virulent mycobacteria, such as BCG vaccines and environmental mycobacteria, in otherwise healthy patients. Patients with MSMD are also vulnerable to tuberculosis and salmonellosis, though other infections are rare. First described clinically in the 1950s, the pathogenesis of MSMD remained unclear until 1996, when its first genetic etiology was deciphered in children with interferon-y receptor 1 (IFN-yRI) deficiency. Genetic dissection of MSMD over the last 18 years has identified 9 morbid genes, including 7 autosomal (IFNGR1, IFNGR2, STAT1, IL12B, IL12RB1, IRF8, ISG15) and 2 X-linked (NEMO, CYBB) genes. The high level of allelic heterogeneity at these loci has led to the definition of 18 distinct disorders. The pathogenesis of MSMD in patients with these disorders involves impaired interleukin-12 (IL-12)-dependent IFN-y immunity. However, only about half of the 700 patients tested in our lab carried any of these genetic defects. We hypothesize that MSMD in other patients results from other monogenic inborn errors of immunity, possibly but not necessarily involving the I L - 1 2 - I F N - Y circuit.
We aim to identify new MSMD-causing genes by following a hypothesis-free, genome-wide (GW) approaches, based on X-linked mapping for defects in X-linked genes, homozygosity mapping for defects in autosomal genes, and whole-exome sequencing (WES) for other novel MSMD-causing defects. Our discoveries neatly illustrate the power of GW approaches, particularly WES. From a basic biological standpoint, this research will provide considerable and novel insights into the mechanisms of immunity to mycobacteria. Elucidation of the molecular genetic basis of MSMD will also shed light on the pathogenesis of mycobacterial disease, making it possible to provide molecular diagnoses for patients and genetic counseling for families. This new information will pave the way for the use of IFN-y or other cytokines for the treatment of mycobacterial diseases, in addition to antibiotics. Finally, the genetic dissection of MSMD will pave the way for the genetic dissection of severe tuberculosis in otherwise healthy children.

Public Health Relevance

The known genetic etiologies of Mendelian susceptibility to mycobacterial disease (MSMD) impair interferon (IFN)-v-mediated immunity. Nearly half the patients with MSMD lack a genetic etiology. We hypothesize that MSMD in these patients also results from inborn errors of immunity, which we aim to identify using hypothesis-free, GW approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
4R37AI095983-06
Application #
8964609
Study Section
Special Emphasis Panel (NSS)
Program Officer
Voulgaropoulou, Frosso
Project Start
2011-05-01
Project End
2021-04-30
Budget Start
2016-05-01
Budget End
2017-04-30
Support Year
6
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Rosain, Jérémie; Kong, Xiao-Fei; Martinez-Barricarte, Ruben et al. (2018) Mendelian susceptibility to mycobacterial disease: 2014-2018 update. Immunol Cell Biol :
Esteve-Solé, Ana; Sologuren, Ithaisa; Martínez-Saavedra, María Teresa et al. (2018) Laboratory evaluation of the IFN-? circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease. Crit Rev Clin Lab Sci 55:184-204
Rosain, Jérémie; Oleaga-Quintas, Carmen; Deswarte, Caroline et al. (2018) A Variety of Alu-Mediated Copy Number Variations Can Underlie IL-12R?1 Deficiency. J Clin Immunol :
Bucciol, Giorgia; Moens, Leen; Bosch, Barbara et al. (2018) Lessons learned from the study of human inborn errors of innate immunity. J Allergy Clin Immunol :
Kong, Xiao-Fei; Martinez-Barricarte, Ruben; Kennedy, James et al. (2018) Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol 19:973-985
Casanova, Jean-Laurent; Abel, Laurent (2018) Human genetics of infectious diseases: Unique insights into immunological redundancy. Semin Immunol 36:1-12
Abel, Laurent; Fellay, Jacques; Haas, David W et al. (2018) Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives. Lancet Infect Dis 18:e64-e75
Louvain de Souza, Thais; de Souza Campos Fernandes, Regina C; Azevedo da Silva, Juliana et al. (2017) Microbial Disease Spectrum Linked to a Novel IL-12R?1 N-Terminal Signal Peptide Stop-Gain Homozygous Mutation with Paradoxical Receptor Cell-Surface Expression. Front Microbiol 8:616
Kagawa, Reiko; Fujiki, Ryoji; Tsumura, Miyuki et al. (2017) Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants. J Allergy Clin Immunol 140:232-241
Hatipoglu, Nevin; Güvenç, B Haluk; Deswarte, Caroline et al. (2017) Inherited IL-12R?1 Deficiency in a Child With BCG Adenitis and Oral Candidiasis: A Case Report. Pediatrics 140:

Showing the most recent 10 out of 45 publications